- Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?on January 21, 2025 at 7:35 pm
Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and Goliath dynamic” in 2024, report says.
- FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatmenton January 21, 2025 at 6:57 pm
Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.
- GLP-1s and Brian Thompson’s killing loom large at top health-care conferenceon January 19, 2025 at 2:40 pm
This year's JPMorgan health-care conference took place a month after UnitedHealthcare CEO Brian Thompson was fatally shot in New York City.
- Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medicationson January 17, 2025 at 11:36 pm
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.
- Medicare's new $2,000 cap on out-of-pocket drug costs could save patients thousands, AARP sayson January 16, 2025 at 11:32 am
The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid arthritis, and other conditions.
- Stocks pop on cool inflation, hot bank earnings — plus, new rules on biotech exports to Chinaon January 15, 2025 at 7:56 pm
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
- Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drugon January 15, 2025 at 5:18 pm
Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the latter part of the year.
- Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demandon January 14, 2025 at 9:33 pm
Eli Lilly shares dropped after the drugmaker cut its 2024 revenue guidance, citing lower-than-expected demand for its obesity and diabetes drugs.
- Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care dealson January 14, 2025 at 9:31 pm
Companies from Johnson & Johnson to Eli Lilly, Amazon and Nvidia are announcing health-related deals at the JPMorgan Health Care Conference.
- Health care jobs are in demand in 2025 — one of the top roles can pay $385,000on January 14, 2025 at 2:57 pm
An aging U.S. population and lower risk of replacement by A.I. has contributed to strong demand for health care workers.
Click Advertiser ♥